Our own recent study based on a Swedish (mainly Caucasian) SLE population concluded that IgA aPL alone are of additional value only for patients with a high probability of APS, despite negative test outcomes for IgG/IgM aCL, anti-β2GPI and LA (23). Here, ACLY is linked to autoimmune polyendocrinopathy.